Provided by Tiger Trade Technology Pte. Ltd.

X4 Pharmaceuticals Inc

4.16
+0.11002.72%
Post-market: 4.160.00000.00%19:30 EDT
Volume:390.76K
Turnover:1.62M
Market Cap:412.45M
PE:-3.35
High:4.18
Open:4.05
Low:4.00
Close:4.05
52wk High:4.83
52wk Low:2.80
Shares:99.15M
Float Shares:62.35M
Volume Ratio:0.69
T/O Rate:0.63%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2404
EPS(LYR):-1.8726
ROE:-113.08%
ROA:-28.15%
PB:2.65
PE(LYR):-2.22

Loading ...

Aug 09, 2019

Employee Stock Ownership

Securities to be offered to employees in employee benefit plans
Aug 09, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Aug 07, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Jul 17, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Jun 28, 2019

Major Issues Report

Current report, items 1.01, 2.03, and 9.01
Jun 26, 2019

Major Issues Report

Current report, items 8.01 and 9.01
Jun 19, 2019

Major Issues Report

Current report, items 5.02, 5.07, and 9.01
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
Jun 19, 2019

Statement Of Changes In Beneficial Ownership

Statement of changes in beneficial ownership of securities
May 28, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
May 17, 2019

Major Issues Report

[Amend] Current report, item 5.02
May 15, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
May 13, 2019

Major Issues Report

[Amend] Current report, item 9.01
Apr 26, 2019

Beneficial Ownership Change

[Amend] General statement of acquisition of beneficial ownership
Apr 15, 2019

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Apr 12, 2019

Major Issues Report

Current report, items 2.02, 8.01, and 9.01
Apr 12, 2019

[Supp]Public Prospectus

Filing under Securities Act Rules 163/433 of free writing prospectuses
Apr 11, 2019

Major Issues Report

Current report, items 8.01 and 9.01